The largest database of trusted experimental protocols

6 protocols using calretinin

1

Histological Analysis of Intestinal Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were euthanized by inhalation of a 5% CO2 / 95% O2 followed by 100% CO2 for 4 min, and transcardially perfused with PBS to remove blood. Human and mouse formalin-fixed paraffin-embedded 5-μm-thick small intestine tissue sections were routinely stained for Hematoxylin-Eosin and Phosphotungstic acid-hematoxylin and immunostained as described [18 (link)] against smooth muscle actin (SMA, Dako, 1:200), CD117/c-kit (Dako, 1:50), calretinin (Dako, 1:200), NeuN (Millipore, 1:100), CD3 (Dako, 1:250), CD8 (Dako, 1:50) and glial fibrillary acidic protein (GFAP, Dako, 1:300). Immunoreactivity was detected using 3,3'-Diaminobenzidin or Liquid Permanent Red as chromogen. Pictures were taken with a Leica DM3000 microscope. Muscle thickness was measured on transversally cut intestinal sections (N = 40 for mice, N ≥ 25 for humans). Quantification of muscle wall thickness and ganglion cell density was performed blind to the genotype with ImageJ.
+ Open protocol
+ Expand
2

Histological Analysis of Ovarian Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors excised from the peritoneal cavity of 32 patients with epithelial ovarian cancer (stage III and IV) as well as fragments of tumor-free peritoneum from the same patients were included in the study. The age of patients ranged from 42 to 60 years. The tissues were fixed in 4% formalin and were then processed as described in11 (link). The cancer tissue was identified using standard H + E staining. Peritoneal mesothelium located near the cancer cells was identified based on positive stainings of the D2-40, Wt-1, HBME-1, and calretinin with specific antibodies (Dako, Santa Clara, CA). Antigen visualization was performed using an Envision Flex (Dako).
+ Open protocol
+ Expand
3

Immunohistochemical Characterization of Peritoneal Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed, paraffin-embedded sections from the peritoneal xenografts were examined as previously described [10 (link)]. Visualization was achieved using the EnVision + peroxidase system (Dako, Glostrup, Denmark). The antibodies used were against EpCAM and MUC4 (Abcam, Cambridge, UK), as well as Ber-EP4, carcinoembryonic antigen (CEA), calretinin, WT-1, CK20, CK7 and CDX2 (Dako). In addition the antibodies PAX8 (Abnova, Taipei City, Taiwan), B72.3 (BioGenex, Fremont, CA), Claudin-3 (CLD3) (Zymed, San Fransisco, CA), and Villin (Immunotec, Indianapolis, IN) were used. Negative control consisted of sections that underwent similar staining procedures with nonrelevant rabbit immunoglobulins or a monoclonal antibody of the same isotype as the primary antibody used. For all antibodies, positive controls were included with satisfactory results. The study pathologist (BD) evaluated immunohistochemical staining.
+ Open protocol
+ Expand
4

Comprehensive Immunohistochemical Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was performed in the Johns Hopkins Immunopathology Laboratory on formalin-fixed, paraffin-embedded tissue sections, using Ventana Benchmark automation and the Ultra View detection kit (Ventana Medical Systems, Tucson, AZ, USA) as previously described [26 (link),27 (link)]. All immunostains were performed at the time of diagnosis for primary or recurrent tumor. Antibodies from Cellmarque, Hot Springs, AZ, included: c-Kit (YR145), DOG-1 (SP31), CAM5.2 (B22.1&B23), Calretinin (Polyclonal), Cyclin D1 (SP4); antibodies from Ventana, Tucson, AZ, USA, included: CD34 (QBE/10), CD68 (KP-1), SMA (1A4), AE1/AE3 (pck-26), Actin (MOUSE), S100 (4C4.9), ER (SP-1), Melan A (A103); antibodies from DAKO, Carpinteria, CA, USA, included Desmin (D33) and Caldesmon (h-CD); antibodies from Abcam, Cambridge, MA, included ALK (5A4), Cathepsin K (3F9), and SDHB (21A11AE7); antibodies from Leica, Bannock Burn, IL, USA, included CD10 (MS/56C6) and PR (1E2); the rest of the antibodies included SOX-10 (N-20, Biocare, Concord, CA, USA), HMB-45 (HMB45, Novocastra, Newcastle upon Tyne, UK), Inhibin (R1, Serotec, Raleigh, NC), STAT6 (D-1, Santa Cruz, Santa Cruz, CA, USA), and SF-1 (n1665, Invitrogen, Waltham, MA, USA).
+ Open protocol
+ Expand
5

Comprehensive Immunofluorescence Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescence experiments were performed essentially as described5 ,10 (link). Antibodies used include Calbindin (1:1,000, Swant, 300), Calretinin (mouse, 1:500, DAKO, M7245), Calretinin (mouse, 1:1,000, Swant, 6B3), Somatostatin (rabbit, 1:5,000, Bachem, T-4103.00), NKX2-1 (mouse, 1:300, Invitrogen, 18-0221), ISLET1 (mouse, 1:100, DSHB, 39.3F7), Pan DLX (rabbit, 1:1,000, gift from Y.M. Morozov, Department of Neurobiology, Yale University School of Medicine), NeuN (mouse, 1:100, Millipore, MAB377), GAD1 (mouse, 1:1,000, Millipore, MAB5406), GAD2 (mouse, 1:500, DSHB, GAD6), Synapsin-1 (rabbit, 1:1,000, Synaptic System, 106-002), DCX (rabbit, 1:1,000, Cell Signaling, 4604S), OLIG2 (rabbit, 1:1,000, Millipore, AB9610), TUJ1 (mouse, 1:1,000, Covance, MMS-435P), TUJ1 (rabbit, 1:1,000, Covance, MRB- 435P), VGAT (mouse, 1:1,000, Synaptic System, 131 003), Human nuclei antigen (mouse, 1:100, Millipore, MAB1281), GFP (chicken, 1:1,000, Aves Labs, GFP-1020), COUPTFII (mouse, 1:300, Perseus Proteomics, PP-H7147-00), MAP2 (chicken, 1:20,000, Abcam, AB5392), MAP2 (mouse, 1:500, Sigma Aldrich, M4403), GABA (rabbit, 1:1,000, Sigma Aldrich, A2052), Parvalbumin (mouse, 1:1,000, Sigma, P3088) (see also Supplementary Table 1).
+ Open protocol
+ Expand
6

Immunohistochemical Analysis of Lung Biopsies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung biopsies were obtained during redo-transplantation, VATS-biopsy or autopsy of patients with BOS (n=19) and RAS (n=19). Non-transplant control biopsies (n=14) were obtained during autopsy of patients without underlying lung disease (n=11) or during resection of non-diseased lung tissue from lung carcinoma patients with normal spirometry (n=3). All biopsies were retrieved at random by the Hospitals Pathology Department for routine clinical purposes and not specifically for this study. Paraffin sections were prepared from each biopsy and stained with calretinin (Dako, Agilent, Heverlee, Belgium) and/or TGF-β1 (Atlas, Bromma, Sweden) antibody (supplementary method 2 & 3). Control stainings for TGF-β1 were performed on liver and tonsil biopsies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!